TAYLOR BATTAGLIA: Open Payments
NPI 1104478981 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 36 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $559 · 2025 $875
Food & beverage: $785Education: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $347 |
| GENZYME CORPORATION | 4 | $109 |
| Insmed, Inc. | 4 | $76 |
| JAZZ PHARMACEUTICALS INC. | 3 | $74 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Resmed Corp | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Verona Pharma, Inc. | 1 | $28 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
Products named: NUCALA, DUPIXENT, TRELEGY ELLIPTA, Arikayce, XYWAV, AIRSENSE, Ohtuvayre, OFEV.
Industry payments across CA — which companies pay providers there.
